The Supreme Court in Amgen Inc. v. Sanofi, 143 S. Ct. 1243 (2023) recently re-examined the requirement under 35 U.S.C. §112(a) that the specification of a patent must describe the invention.
The Supreme Court’s lone patent case from last term does not break new ground on enablement law. The Court’s core holdings that a patent specification must enable the full scope of the.
On January 10, 2024, the United States Patent and Trademark Office issued Guidelines for Assessing Enablement in Utility Applications and Patents in View of the U.S. Supreme Court Decision in Amgen.
On January 10, 2024, the United States Patent and Trademark Office (USPTO) issued "Guidelines for Assessing Enablement in Utility Applications and Patents in View of the U.S. Supreme.